Correlation Between Tonix Pharmaceuticals and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Moleculin Biotech, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Moleculin Biotech.
Diversification Opportunities for Tonix Pharmaceuticals and Moleculin Biotech
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tonix and Moleculin is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Moleculin Biotech go up and down completely randomly.
Pair Corralation between Tonix Pharmaceuticals and Moleculin Biotech
Given the investment horizon of 90 days Tonix Pharmaceuticals is expected to generate 1.65 times less return on investment than Moleculin Biotech. But when comparing it to its historical volatility, Tonix Pharmaceuticals Holding is 1.96 times less risky than Moleculin Biotech. It trades about 0.05 of its potential returns per unit of risk. Moleculin Biotech is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 179.00 in Moleculin Biotech on December 28, 2024 and sell it today you would lose (74.00) from holding Moleculin Biotech or give up 41.34% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Tonix Pharmaceuticals Holding vs. Moleculin Biotech
Performance |
Timeline |
Tonix Pharmaceuticals |
Moleculin Biotech |
Tonix Pharmaceuticals and Moleculin Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tonix Pharmaceuticals and Moleculin Biotech
The main advantage of trading using opposite Tonix Pharmaceuticals and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. iBio, Common Stock | Tonix Pharmaceuticals vs. Jaguar Animal Health |
Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Stocks Directory Find actively traded stocks across global markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |